4//SEC Filing
Markels John 4
Accession 0001209191-23-034396
CIK 0001001233other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:49 PM ET
Size
7.9 KB
Accession
0001209191-23-034396
Insider Transaction Report
Form 4
Markels John
Director
Transactions
- Award
Common Stock
2023-06-01+13,900→ 46,384 total - Award
Stock Option (Right to Buy)
2023-06-01+27,750→ 27,750 totalExercise: $1.11Exp: 2033-05-31→ Common Stock (27,750 underlying)
Footnotes (2)
- [F1]Represents shares of common stock issuable upon settlement of a restricted stock unit grant that will fully vest on the earlier of (a) June 1, 2024 or (b) the day prior to the 2024 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through such date and subject to acceleration as provided in the 2018 EIP.
- [F2]The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001803424
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:49 PM ET
- Size
- 7.9 KB